NO172438C - Analogifremgangsmaate for fremstilling av terapeutisk aktive ((5(6)(1h-azol-1-ylmetyl)benzimidazol)karbamater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive ((5(6)(1h-azol-1-ylmetyl)benzimidazol)karbamater

Info

Publication number
NO172438C
NO172438C NO890579A NO890579A NO172438C NO 172438 C NO172438 C NO 172438C NO 890579 A NO890579 A NO 890579A NO 890579 A NO890579 A NO 890579A NO 172438 C NO172438 C NO 172438C
Authority
NO
Norway
Prior art keywords
azol
carbamates
ylmethyl
benzimidazole
preparation
Prior art date
Application number
NO890579A
Other languages
English (en)
Norwegian (no)
Other versions
NO172438B (no
NO890579D0 (no
NO890579L (no
Inventor
Alfons Herman Marg Raeymaekers
Eddy Jean Edgard Freyne
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO890579D0 publication Critical patent/NO890579D0/no
Publication of NO890579L publication Critical patent/NO890579L/no
Publication of NO172438B publication Critical patent/NO172438B/no
Publication of NO172438C publication Critical patent/NO172438C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO890579A 1988-02-12 1989-02-10 Analogifremgangsmaate for fremstilling av terapeutisk aktive ((5(6)(1h-azol-1-ylmetyl)benzimidazol)karbamater NO172438C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/155,464 US4826862A (en) 1988-02-12 1988-02-12 Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates

Publications (4)

Publication Number Publication Date
NO890579D0 NO890579D0 (no) 1989-02-10
NO890579L NO890579L (no) 1989-08-14
NO172438B NO172438B (no) 1993-04-13
NO172438C true NO172438C (no) 1993-07-21

Family

ID=22555544

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890579A NO172438C (no) 1988-02-12 1989-02-10 Analogifremgangsmaate for fremstilling av terapeutisk aktive ((5(6)(1h-azol-1-ylmetyl)benzimidazol)karbamater

Country Status (17)

Country Link
US (1) US4826862A (fr)
EP (1) EP0328203A3 (fr)
JP (1) JPH01228986A (fr)
CN (1) CN1022245C (fr)
AU (1) AU605406B2 (fr)
DK (1) DK64089A (fr)
FI (1) FI890654L (fr)
IL (1) IL89249A (fr)
MA (1) MA21493A1 (fr)
MY (1) MY104979A (fr)
NO (1) NO172438C (fr)
NZ (1) NZ227801A (fr)
PH (1) PH27056A (fr)
PT (1) PT89659B (fr)
SU (1) SU1706389A3 (fr)
TN (1) TNSN89015A1 (fr)
ZA (1) ZA891079B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943574A (en) * 1987-06-01 1990-07-24 Janssen Pharmaceutica N.V. (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
US5039677A (en) * 1987-06-01 1991-08-13 Janssen Pharmaceutica N.V. 6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles
US5072453A (en) * 1990-03-08 1991-12-17 Nathaniel Widder Body protection system
US5374615A (en) * 1990-10-31 1994-12-20 E. R. Squibb & Sons, Inc. Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives
PH31175A (en) * 1990-10-31 1998-03-20 Squibb & Sons Inc Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
GB9115272D0 (en) * 1991-07-15 1991-08-28 Pfizer Ltd Benzimidazole anthelmintics
GB9115273D0 (en) * 1991-07-15 1991-08-28 Pfizer Ltd Benzimidazole anthelmintics
DE4142731A1 (de) * 1991-12-21 1993-06-24 Hoechst Ag Biozide polymerisate und polymerisatdispersionen, verfahren zu ihrer herstellung und ihre verwendung
GB9205368D0 (en) * 1992-03-12 1992-04-22 Pfizer Ltd Benzimidozole anthelmintic agents
US5278181A (en) * 1992-05-12 1994-01-11 Board Of Regents Acting On Behalf Of The University Of Michigan Soluble alkyl[5-[amino (phenyl)methyl]-1H-benzimidazol-2-yl] carbamate anthelmintics
GB9501737D0 (en) * 1994-04-25 1995-03-22 Hoffmann La Roche Hydroxamic acid derivatives
US20040170735A2 (en) * 2002-04-05 2004-09-02 Mcneil-Ppc, Inc. Methods and compositions for altering the sweetness delivery profile of sucralose
US20040086605A1 (en) * 2002-10-30 2004-05-06 Sox Thomas E. Composition for delivering a high intensity sweetener
US20040247014A1 (en) * 2003-05-02 2004-12-09 Vache John P Methods and apparatus for indicating temperature-related events

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US3969526A (en) * 1973-05-29 1976-07-13 Smithkline Corporation Anthelmintic 5-heterocycliothio and oxy-2-carbalkoxyaminobenzimidazles
US4512998A (en) * 1980-10-20 1985-04-23 Schering Corporation Anthelmintic benzimidazole carbamates
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
CN1036014A (zh) 1989-10-04
NO172438B (no) 1993-04-13
EP0328203A3 (fr) 1990-03-14
DK64089A (da) 1989-08-13
TNSN89015A1 (fr) 1991-02-04
SU1706389A3 (ru) 1992-01-15
NZ227801A (en) 1990-10-26
PT89659B (pt) 1994-02-28
US4826862A (en) 1989-05-02
EP0328203A2 (fr) 1989-08-16
PT89659A (pt) 1989-10-04
MA21493A1 (fr) 1989-10-01
PH27056A (en) 1993-02-01
AU605406B2 (en) 1991-01-10
FI890654A7 (fi) 1989-08-13
IL89249A (en) 1993-03-15
CN1022245C (zh) 1993-09-29
AU2966589A (en) 1989-08-17
FI890654A0 (fi) 1989-02-10
IL89249A0 (en) 1989-09-10
NO890579D0 (no) 1989-02-10
MY104979A (en) 1994-07-30
NO890579L (no) 1989-08-14
JPH01228986A (ja) 1989-09-12
FI890654L (fi) 1989-08-13
DK64089D0 (da) 1989-02-10
ZA891079B (en) 1990-10-31

Similar Documents

Publication Publication Date Title
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO914667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
NO173017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nor-statin- eller nor-cyklostatinpolypeptider
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO171787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser
NO168174C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser
NO172240C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2'-halometylidenderivater
NO172438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ((5(6)(1h-azol-1-ylmetyl)benzimidazol)karbamater
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO171856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO172849C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater
NO854369L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO171857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
NO173185C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO170582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO169169C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte benzimidazoler
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner